Wegovy

Carolina Rudah Novo Nordisk (NVO) is up 2.1% in premarket trade after the company’s Wegovy weight loss treatment was approved in the world’s second-largest economy. It’s a big market for blockbuster drug. More than half of Chinese people age 18 and older are obese or overweight, according to China’s NationalContinue Reading